October 14, 2020
Thank you for choosing the online registration. Please complete the registration form below and an acknowledgment will be sent to you by email. Places are strictly limited.   Wednesday, 21 October 2020 at 3.00-4.00pm Hong Kong time Fees: FREE 提供中英文同传服务 Bilingual: Putonghua and English Simultaneous translation available    Presented by Department of Justice, Hong Kong Special Administrative Region of the People’s Republic of...
June 24, 2020
Praxonomy has partnered with the In-House Community to offer our members a very special offer. Praxonomy is an easy-to-use board portal that manages the full lifecycle of board and committee meetings. Praxonomy enables boards to operate more efficiently while saving time and money.   Special offer for In-House Community Jade members: 6 months free subscription, with 40% discount on subsequent (first year) annual subscription   Special offer for In-House Community Standard members: 30-day free trial, with a 30% discount on first year subscription Promotion validity: Application before September 2020 For more information or to apply, contact yvette.tan@inhousecommunity.com and quote ‘PraxonomyIHC2020’ in the subject line. Recently, Richard Levick spoke to Jay Shaw, founder and Chairman at Praxonomy about digital transform and some of the best practices for boards in the age of virtual board meetings. To listen to this episode of The Weekly click here See also: The five stages of the board management maturity model Boards and the Adoption of Remote Working Practices   For more on Praxonomy, visit:...
June 15, 2020
Created in conjunction with a number of our In-House Community Thought Leaders, the Corporate Counsel Credo is intended to help counsel meet their ethical, legal and business commitments and responsibilities within their organisations.
May 13, 2020
Raise money for Children’s Cancer Therapy Development Institute (cc-tdi.org) “Childhood cancer is a global health issue touching the lives of at least 300,000 children each year according to WHO estimates, but likely as many as 400,000 children with a quarter of these children going undiagnosed in developing countries. Even for children in nations with state of the art care, 1 in 5 children will not survive. Pharmaceutical companies and their internal champions now more than ever are reaching past the new regulatory requires to test adult cancer drugs for effectiveness in children; however, while US FDA approvals for adult cancer number on average 12 or more each year – for children, effective drugs for pediatric cancer have only been approved 8 times in the last 42 years. See auction and giveaways below. The 2019 fundraising support of In-House Community and their clients super-charged childhood cancer research at the Children’s Cancer Therapy Development Institute (cc-tdi.org), and this year promises to make an even bigger impact. Highlights of supported work at cc-TDI this past year includes a machine learning project to help improve the diagnosis of children with cancer in developing countries, and developed ones. This project was piloted with the Intel spinout OmicsAutomation.com, and complemented by design of a pocket microscope slide scanner by a capstone engineering team at the University of Idaho. The project is hoped to move to the IBM World Community Grid Smash Childhood Cancer Project, led by Dr. Godfrey Chan (Hong Kong University), and for which cc-TDI is a major participant. This project is a key example of how it takes a community to address a...